Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03339258 · ClinicalTrials.gov registry record · Phase 2
A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
A Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by San Francisco Veterans Affairs Medical Center.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03339258: Active Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by San Francisco Veterans Affairs Medical Center.
NCT03339258 is a Phase 2 study of Stress Disorders, Post-Traumatic that is active but no longer recruiting, run by San Francisco Veterans Affairs Medical Center. The registered enrollment target is 80 participants, below the 155-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03339258, a Phase 2 study of Stress Disorders, Post-Traumatic, is active but no longer recruiting, sponsored by San Francisco Veterans Affairs Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, double-blind, placebo-controlled trial of doxazosin will assess doxazosin's effectiveness for PTSD nightmares, subjective sleep quality, and non-nightmare PTSD symptoms in adult men and women veterans with full and partial-syndromal PTSD.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Doxazosin Mesylate, Extended Release
Study Locations (1)
California
- San Francisco VA Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2024-06 |
| Phase | Phase 2 |
What the registry record for NCT03339258 still lists
NCT03339258 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 155-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03339258 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03339258 about?
NCT03339258 is a clinical study titled "A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD". This randomized, double-blind, placebo-controlled trial of doxazosin will assess doxazosin's effectiveness for PTSD nightmares, subjective sleep quality, and non-nightmare PTSD symptoms in adult men and women veterans with full and partial-syndromal PTSD.
What is the current status of trial NCT03339258?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2018-04-15. Estimated completion is 2024-06.
What conditions does trial NCT03339258 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT03339258?
The interventions under investigation include: Placebo (DRUG), Doxazosin Mesylate, Extended Release (DRUG).
Who is sponsoring clinical trial NCT03339258?
This trial is sponsored by San Francisco Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03339258 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03339258's enrollment target sits among peer trials
80 36th of 66 higher than 29 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
-
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
RECRUITING · Phase 2
-
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Compassion Meditation vs. Health Education for Veterans
ACTIVE NOT RECRUITING · Phase 2
-
Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault
COMPLETED · Phase 2
-
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI